Institute for Precision Health

Research opportunities

Funding

The Institute for Precision Health offers numerous funding opportunities to enhance your research and industrial collaborations via the UKRI MRC Impact Acceleration Accounts (IAA) award. Funding calls will be announced via the Institute and drugdiscovery@le.ac.uk mailbox at several points during the year. There may be further opportunity for small awards in between formal calls, so please email drugdiscovery@le.ac.uk to talk through your ideas.

Additionally, the Institute can provide funding to facilitate networking opportunities for grant development. Please contact Lynne Howells (lh28@le.ac.uk) for further information. 

Postgraduate research

The Institute for Precision Health has an active postgraduate community. New studentships will be announced here, and we welcome enquiries about our PhD projects. 

Our students are undertaking world-leading research in the following areas:

Circulating RNA as a liquid biopsy for cancer detection and tissue-of-origin prediction

Inequalities in precision medicine in under-served groups

Proteomic investigation of markers of chronic inflammation in cardiovascular disease

Functional investigation of a potential novel drug target for progressive lung fibrosis

Developing a virtual asthma patient

Investigation of proteomic biomarkers of hypertension using microsampling-based mass spectrometry detection

  • Elliott Gyedu, supervised by Dr Pankaj Gupta and Dr Dennis Bernieh

Radiomic and multiomic investigation of molecular pathways in concentric left ventricular myocardial remodelling in Type 2 Diabetes (T2DM)

Mechanisms of intrinsic resistance to bispecific antibodies in diffuse large B cell lymphoma (DLBCL)

Understanding the effect of SGLT2i on muscle health in those with chronic disease

Further research

2021

Targeting Mutant FBXW7 to Disable MCL1 and Induce Therapeutic Apoptosis

  • Daniel Rowell Faulkner, supervised by Professor Dean Fennell

Novel therapeutic and diagnostic approaches for EML4-ALK driven lung cancer

  • Savvas Papageorgiou

2020

2019

Back to top
MENU